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A prediction model for colon cancer
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Norm M. Good,a Krithika Suresh,b Graeme P. Young,c
Trevor J. Lockett,d Finlay A. Macraee and Jeremy M. G. Taylorb*†
Dynamic prediction models make use of patient-specific longitudinal data to update individualized survival prob-
ability predictions based on current and past information. Colonoscopy (COL) and fecal occult blood test (FOBT)
results were collected from two Australian surveillance studies on individuals characterized as high-risk based on
a personal or family history of colorectal cancer.Motivated by a Poisson process, this paper proposes a generalized
nonlinear model with a complementary log–log link as a dynamic prediction tool that produces individualized
probabilities for the risk of developing advanced adenoma or colorectal cancer (AAC). This model allows pre-
dicted risk to depend on a patient’s baseline characteristics and time-dependent covariates. Information on the
dates and results of COLs and FOBTs were incorporated using time-dependent covariates that contributed to
patient risk of AAC for a specified period following the test result. These covariates serve to update a person’s risk
as additional COL, and FOBT test information becomes available. Model selection was conducted systematically
through the comparison of Akaike information criterion. Goodness-of-fit was assessed with the use of calibration
plots to compare the predicted probability of event occurrence with the proportion of events observed. Abnormal
COL results were found to significantly increase risk of AAC for 1 year following the test. Positive FOBTs were
found to significantly increase the risk of AAC for 3months following the result. The covariates that incorporated
the updated test results were of greater significance and had a larger effect on risk than the baseline variables.
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There is a well-established model for colorectal cancer (CRC) development [1]. CRC begins as benign
polyps that grow over time in the lining of the colon. Individuals are more susceptible to developing
polyps if they are aged 50 years or older, have a personal or family history of polyps, and/or have inher-
ited gene mutations known to be associated with colon polyps. Most of these polyps, characterized as
hyperplastic polyps, will remain benign for the lifetime of the individual, with a very low chance of
becoming cancer. Some polyps, known as adenomas, may become cancerous if not removed. The risk of
an adenoma developing into cancer increases with adenoma size and the period it has been growing in
the colon. A person is said to have advanced adenoma if an adenoma is large (⩾10mm), if an adenoma
has certain characteristics (tubulovillous, villous histology, or high-grade dysplasia), or if the person has
three or more adenomas. Advanced adenoma is a surrogate for present and future CRC risk [2]. Malignant
adenomas that are not removed in the early stages can develop into invasive CRC. As the cancer grows,
it may infiltrate neighboring structures, which if undetected and untreated would lead to the individual
experiencing symptoms. CRC is one of the most common cancers, and treatments are only moderately
effective, particularly for more advanced disease. CRC survival rates are improved with early diagno-
sis; thus, there is a great interest in methods for early detection and prevention. There are a number of
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tests for detecting early signs of CRC, such as a colonoscopy (COL), a fecal occult blood test (FOBT), a
sigmoidoscopy, many variations of these tests, and new biomarker-based tests. These tests have proper-
ties, risks, and expenses associated with them, so an important medical and public health problem is the
judicious use of these tests.
A colonoscopy is a procedure by which adenomas and cancers are visually looked for by inserting a
tube into the colon. As part of the procedure, any adenomas that can be found are resected, removed,
and subsequently examined to see if they contain cancer. Thus, a colonoscopy is both a detection and a
prevention method because it removes adenomas that are or may become malignant. A FOBT is a test
of whether blood is detected in the stool. It is not specific to adenomas or cancers, but for mechanical
reasons, larger adenomas and cancers are more likely to be bleeding, and hence more likely to give rise
to a positive FOBT. In practice, a positive FOBT is usually quickly followed up by a COL. When these
tests are applied in the general low-risk population, it is called screening. When the tests are applied
in a population who are considered high risk for CRC, it is called surveillance. There are a number of
published guidelines for the use of these tests in the screening and surveillance setting [3–8].
In this paper, we will be developing a dynamic individual prediction model from a data set of high-risk
individuals who are in a surveillance program. The increasing availability of longitudinal patient infor-
mation enables individualized dynamic predictions [9, 10]. For a given individual, dynamic prediction
models predict the probability of an event occurring in an interval by conditioning on the individual’s lon-
gitudinal patient history of tests. In addition to varying between individuals, the risk of developing CRC
changes over the trajectory of an individual’s life. The benefit of these models is the ability to update
patient risk at each colonoscopy and FOBT while still incorporating the effect of previous test results.
This paper presents an approach to analyzing data from studies of serial colonoscopies in individuals
who are at high risk for colon cancer. The primary goal is to provide a method that gives individual
predictions based on a person’s characteristics and the results from their sequence of FOBT and COL
tests. Specifically, the aim is to estimate the distribution of times to the development of the disease for
a person at the time of a colonoscopy or at any specified age. Because cancers are relatively rare, we
characterize the disease, or event of interest, as the development of an advanced adenoma or cancer. The
prediction, which will be in the form of a distribution function, may be a useful ingredient for individual
recommendations or for an overall surveillance policy. For example, someone who is estimated to have
a very low risk of developing a new advanced adenoma or cancer in the next 5 years would likely not be
scheduled for a COL in the immediate future, compared with someone with a high risk who should be
scheduled for a COLmuch sooner. The prediction model we present will also use information on simpler
covariates, such as gender and family history of CRC, as they are also likely to influence the estimates
of someone’s risk.
While the data are rich in information, there are complicating aspects associated with it that require
careful and potentially non-standard statistical approaches. These data were collected over a number of
years, and the guidelines for when COLs and FOBTs should be scheduled have changed during that
period. The number of colonoscopies per patient is quite variable, and the time interval between colono-
scopies is heterogeneous both within and between people. The development of advanced adenoma or
cancer is something that happens in continuous time, but observations about that process are only made
at the time of COLs, leading to interval-censored data. A person can have more than one observed occur-
rence of advanced adenoma or cancer during their follow-up. The COL and FOBT results can be regarded
as time-dependent covariates that provide information about an individual’s risk. There are more sub-
tle issues too, such as the frequency of colonoscopies, which itself is a measure of risk and is impacted
by prior results. We will not attempt to address all the issues in this paper, but rather limit ourselves to
providing a statistical framework that can be used for prediction purposes.
The statistical approach we develop regards the time of development of the event as arising in contin-
uous time from a Poisson process, as has been used by others in colon cancer research [11]. Treating the
event times as interval-censored, we formulate a likelihood function and proceed with maximum likeli-
hood estimation. As a consequence of the Poisson process assumption, we show that our binary outcome
data can be modeled using a generalized nonlinear model with a complementary log–log link, which
facilitates estimation using standard software.
The paper is organized as follows. We describe the data in Section 1, and the model and the estima-
tion method in Section 2. The results including parameter estimates and goodness-of-fit are presented in
Section 3. An example of individualized predictions of risk is demonstrated in Section 4. We finish with
a discussion of model limitations and alternative strategies for future model adaptations.
Copyright © 2015 John Wiley & Sons, Ltd. Statist. Med. 2015, 34 2662–2675
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1. Colorectal cancer surveillance data
1.1. Data
The data come from two surveillance programs in Adelaide (7670 participants) [12–14] and Melbourne
(2829 participants) [15, 16], and are also described in other literature [17]. The data were collected over
the period 1 January 1976 to 3 August 2010. The total number of colonoscopies recorded during this
period is 20,056. Patients with only one recorded colonoscopy, of which there are 4550 (3818 from
Table I. Descriptive statistics for the study cohort used in analysis.
Variable Adelaide Melbourne Combined
Patients 3499 1059 4558
Average Age at index (SD) 63.7 (11.4) 54.0 (8.8) 61.4 (11.6)
Female (%) 1612 (46.1) 683 (64.5) 2295 (50.4)
Family History (%)†
R0 2430 (69.4) 46 (4.3) 2476 (54.3)
R1 150 (4.3) 108 (10.2) 258 (5.7)
R2 224 (6.4) 173 (16.3) 397 (8.7)
R3 234 (6.7) 107 (10.1) 341 (7.5)
R4 407 (11.6) 273 (25.8) 680 (14.9)
CCC 0 (0) 83 (7.8) 83 (1.8)
HNPCC-suspected 23 (0.7) 126 (11.9) 149 (3.3)
HNPCC-definite 31 (0.9) 143 (13.5) 174 (3.8)
Colonoscopies 9,704 3,723 13,427
Colonoscopies per patient (%)
2 1961 (56.0) 345 (32.6) 2306 (50.6)
3 881 (25.2) 268 (25.3) 1149 (25.2)
4 365 (10.4) 177 (16.7) 542 (11.9)
5+ 292 (8.3) 269 (25.4) 561 (12.3)
Reason for Colonoscopy (%)
Surveillance (<9 months since previous COL) 2101 (21.7) 525 (14.1) 2626 (19.6)
Surveillance (≥9 months since previous COL) 4120 (42.5) 2560 (68.8) 6680 (49.8)
Symptoms 2005 (20.7) 50 (1.3) 2055 (15.3)
Positive FOBT 1255 (12.9) 381 (10.2) 1636 (12.2)
Abnormal CT/Other 223 (2.3) 207 (5.6) 430 (3.2)
Colonoscopy Result (%)
Normal 4160 (42.9) 2011 (54.0) 6171 (46.0)
Hyperplastic 766 (7.9) 369 (9.9) 1135 (8.5)
Adenoma 1795 (18.5) 267 (7.2) 2062 (15.4)
Advanced adenoma 1497 (15.4) 275 (7.4) 1772 (13.2)
CRC 453 (4.7) 24 (0.6) 477 (3.6)
Other 1033 (10.6) 777 (20.9) 1810 (13.5)
FOBTs 10,944 8999 19,943
FOBT result (%)
Positive 1036 (9.5) 762 (8.5) 1798 (9.0)
†R0 – No family history but a personal history of adenoma or cancer.
R1 – CRC both parents; CRC two siblings; CRC parent and sibling; CRC twins.
R2 – CRC parent and grandparent; One first degree relative plus other family members with
CRC; CRC parent and parent’s sibling.
R3 – CRC first degree relative under 55 years of age.
R4 – CRC first degree relative over 55 years of age; CRC second or third degree relative.
CCC - Cluster of common colorectal cancers, that is, three or more first degree relatives with
CRC all over 50 years at diagnosis.
HNPCC-suspected – suspected HNPCC, that is, two Amsterdam criteria.
HNPCC-definite – definite HNPCC Individuals in families meeting Amsterdam criteria, or car-
rying a mismatch repair mutation. SD, standard deviation; HNPCC, hereditary nonpolyposis
colorectal cancer; CRC, colorectal cancer, COL, colonoscopy; FOBT, fecal occult blood test.
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Adelaide and 732 from Melbourne), are not included in the data analysis because of the lack of follow-
up. The two surveillance programs have different recruitment strategies. The Melbourne study recruits
high-risk individuals based on a family history of CRC, and thus has a younger average age at first COL
compared with Adelaide study, which recruits individuals with both a family and a personal history of
CRC. The Melbourne study also has a larger average number of COLs per person. The eligibility criteria
for the studies were that participants had to be at high risk for CRC based on a personal history of CRC or
adenomas, or a family history of CRC. For the purpose of this paper, individuals younger than 40 years
old at their first COL were excluded and only 20 years of follow-up data were retained for each patient.
Summary statistics for the cohort used in our analysis are given in Table I.
The data consist of serial results of COLs and FOBTs, the dates at which these were measured, the
reason for the test, and other information about the individual (age, gender, family history of colorectal
cancer, and date of death). The result of each COL is a categorical variable taking one of six values:
Normal, Other, Hyperplastic, Adenoma, Advanced adenoma, or CRC. For many patients, the scheduling
of colonoscopies was dynamic, with the planned time of the next colonoscopy generally dependent on
the result of the current colonoscopy. For someone with a clear (normal) colonoscopy, the typical interval
to the next colonoscopy was 5 years; if a small lesion was found the typical interval was 3 years; if a
serious lesion was found, the typical interval was 1 year. However, there are substantial departures from
this pattern. The average time between successive COLs in the studied group is 3 years (SD = 1.8 years).
The result of the FOBT is binary, either positive or negative. The timing of the FOBT was more variable.
In some patients, it was every year, whereas in others, it was seldom. If a patient had a positive finding
on a FOBT, it was nearly always followed by a COL within 3months. For 101 colonoscopies (87 from
Adelaide, 14 from Melbourne) that were characterized as being conducted because of a positive FOBT
result, there was no prior positive FOBT result in the data set. For these cases, a prior positive FOBT result
was assumed to have occurred andwas coded into the data as occurring 1month prior to the corresponding
colonoscopy.
2. Statistical model and estimation
2.1. Notation
Let 𝜏ij be the age of patient i (i = 1,… , n) at their j-th colonoscopy (COL) (j = 1,… ,mi) where patient
i has mi ⩾ 2 COLs at ages 𝜏i1,… , 𝜏imi . Let 𝜏i0 be the youngest possible age for a COL, which we take as
40 years old.
The primary outcome variable of interest is the occurrence of advanced adenoma or cancer, denoted
by AAC. The results of the COL for this primary endpoint are denoted by Yi1,… ,Yimi , where Yij = 1
indicates AAC found at age 𝜏ij and Yij = 0 indicates a finding of no AAC at age 𝜏ij.
Let Xi denote the baseline covariates associated with each individual (e.g., gender, family history, and
city) and Xij denote time-varying covariates associated with COL at age 𝜏ij (e.g., a binary indicator that
the reason for the COL is symptoms).
Let Zi(a) denote a vector of time-dependent covariates. Each component of Zi(a) is constructed to
represent some aspect of the knowledge about individual i at age a, for example, summary of FOBT
history or summary of past COL results. Each Zi(a)will be defined at all ages throughout the individuals’
follow-up. In the formulation described in the succeeding texts, we will assume that every Zi is binary,
but the methodology would allow them to be continuous time-dependent variables, for example, the total
number of adenomas found in all previous colonoscopies. There is much flexibility in how the Z’s are
constructed to match various hypotheses that may be of interest. Specific choices for the Z’s will be
discussed later. See Figure 1 for an illustration of the described notation using the COL and FOBT history
of a sample patient.
2.2. Statistical model
Assume that the hazard of an AAC event at age a (in years) for patient i is given by 𝜆i(a). The specific
time at which the AAC event occurs is the first age at which an advanced adenoma or cancer would be
found if a colonoscopy were to be performed at that age. The occurrence of one AAC does not prevent the
occurrence of later AAC events.Wewill assume that the events, if observable, follow a Poisson process for
each person, with intensity denoted by 𝜆i(a). This process is for when a new advanced adenoma or cancer
would appear if the monitoring were continuous. In this formulation, the actual event, if observable,
Copyright © 2015 John Wiley & Sons, Ltd. Statist. Med. 2015, 34 2662–2675
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Figure 1. Illustration of the described notation using the colonoscopy (COL) and FOBT history of sample patient
with mi = 2 COLs (at j = 1, 2) and four fecal occult blood tests (FOBTs) (at ↑s). COL results are indicated by A
(adenoma) and AA (advanced adenoma). FOBT results are indicated by 0 (negative) and 1 (positive). The Xij cor-
responds to the time-varying COL-specific covariate ‘binary indicator that the reason for the COL is symptoms.’
The Yij corresponds to the binary outcome of AAC. Two possible Zi’s are indicated here: (1) A binary indicator
of whether there was a positive FOBT in the past 3months, and (2) A binary indicator of whether the patient ever
had an abnormal COL. For (1) we see the corresponding Z jump to 1 at age 54.7 years, corresponding to a posi-
tive FOBT, and stay there for 3 months, after which it returns to 0. For (2) we see Z jump to 1 at age 55.0 years,
corresponding to an abnormal COL, and stay that for the rest of the individual’s follow-up.
could occur many times. So, for each person, 𝜆i(a) changes with age, and the value at age a represents
the chance of getting an AAC event in the next unit of time. From any age going forward, 𝜆i(a) can be
modified by new information you learn about the person. For example, if a new test were performed at
age 𝜏 and the results suggest this person is at high risk, we would expect 𝜆i(a) to increase at a = 𝜏.
Monitoring for AAC is not carried out continuously, and data are collected about AAC only at the
time of each COL. Based on the model, the number of occurrences of AAC in (𝜏ij−1, 𝜏ij) has a Poisson
distribution with mean (∫ 𝜏ij
𝜏ij−1
𝜆i(a)da); and hence, the probability of at least one AAC in the interval
(denoted by Yij = 1) is
P(Yij = 1) = P
{
event in interval(𝜏ij−1, 𝜏ij)
}
= 1 − exp
{
−∫
𝜏ij
𝜏ij−1
𝜆i(a)da
}
(1)
The rationale for integrating the hazard over the interval (𝜏ij−1, 𝜏ij) is to accumulate the risk of AAC
during intervals between COLs and model the probability of an event being higher following longer
intervals. This reflects a unique data feature that a longer period between COLs represents a longer time
during which advanced adenoma or cancer can develop, thus increasing the risk of AAC at the end of a
longer interval between COLs.
A convenient form is to assume 𝜆i(a) has a proportional hazards structure given by
𝜆i(a) = 𝜆0(a) exp{𝛽Xi + 𝜃Zi(a)} (2)
We expect 𝜆0(a) to be some smooth increasing function of age, and we will assume
𝜆0(a) = exp(𝛼0)(a − 35)𝛼1 (3)
for ages greater than 40 years. We would expect 𝛼1 > 0 because adenoma rate tends to be higher in older
people. Other parametric forms for 𝜆0(a) are possible. For identifiability purposes, 𝛽X does not include
an intercept term because it is captured by 𝛼0.
Combining Equations (1) and (2), and letting pij = P(Yij = 1), it can be seen that
log
{
− log
(
1 − pij
)}
= 𝛽Xi + log
[
∫
𝜏ij
𝜏ij−1
𝜆0(a) exp
{
𝜃Zi(a)
}
da
]
which is a generalized nonlinear model for binary responses with a complementary log–log link.
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The model is further extended to accommodate time-dependent covariates, Xij, that can vary at
different COLs.
log
{
− log
(
1 − pij
)}
= 𝛽1Xi + 𝛽2Xij + log
[
∫
𝜏ij
𝜏ij−1
𝜆0(a) exp{𝜃Zi(a)}da
]
(4)
This model allows the probability of the COL test being positive to be modified by COL specific
covariates, such as the reason for the test being patient symptoms.
2.3. Maximum likelihood estimation
Each patient has mi − 1 intervals, each of which contributes to the likelihood function. Assuming
independence between intervals, the likelihood contribution for patient i is
Li(𝛽, 𝜃, 𝛼) =
mi∏
j=2
{
P
(
Yij = 1
)}Yij {1 − P (Yij = 1)}(1−Yij) (5)
where the expression for P(Yij = 1) comes from Equation (4), and 𝛽, 𝜃, and 𝛼 are parameters, where 𝛼 are
the parameters in the equation for 𝜆0(a). Note that j = 1 is not included in the product for the likelihood;
thus, the results of each person’s first COL are not used as an outcome variable.
The observed data likelihood is then
L(𝛽, 𝜃, 𝛼) =
n∏
i=1
Li(𝛽, 𝜃, 𝛼) (6)
The form of the likelihood in Equations (5) and (6) is identical to that of a binary response model with
Σni=1(mi − 1) observations and assuming independent Bernoulli distributions for each observation. Thus,
it is possible to use software for generalized nonlinear models to obtain the parameter estimates.
Note that the parameters 𝛽 always enter the model in a linear way; however, the parameters 𝜃 and those
in 𝜆0(a) enter into the model in a nonlinear way. For variables Z that do not change between intervals,
there is some simplification. Specifically, their coefficients can be extracted from the integral and will be
included as linear terms 𝜃Z. However, if the Z is a variable that can change between COLs, the parameters
associated with that Z will remain in the nonlinear part of the model.
In this approach, the unit of analysis is the interval between COLs, rather than the person. Thus, for the
purposes of obtaining point estimates, each interval is regarded as conditionally independent. However,
because of the potential correlation between intervals for the same person, the usual information matrix
is not expected to provide valid standard errors. Thus, we will use the bootstrap to obtain standard errors,
where patients are resampled with replacement.
2.4. Discrete parametrization
Because of the large number of time-dependent covariates, to use available software to implement the
integrations in Equation (4), we discretized time into 1-month unit. The integrals in the given model and
likelihood functions are thus approximated by sums. The baseline hazard becomes a step function that
has a jump discontinuity at each month. The ages at which individuals had test results were rounded to the
nearest twelfth of a year. The covariate Zi(a) then represents the value of covariate Z at age a for individual
i, where a is a multiple of 1/12. Every Z is represented by a matrix, where each column corresponds to
a month and each row corresponds to an interval between colonoscopies. The discretized integrals for
each colonoscopy interval are computed by parsing through the columns of the Z matrices. All statistical
analyses and model building were conducted using R 3.0.2 software. Specifically, it is possible to use
the ‘gnm’ package in R to fit the described generalized nonlinear model. However, depending on the
complexity of the functions 𝜆0(a) and Zi(a), the integral on the right hand side of Equation (4) may not
have an analytic closed-form expression. Thus, the development of the model covariates for input into the
‘gnm’ functionwas challenging. An outline of the R code used is presented in the Supporting Information.
Copyright © 2015 John Wiley & Sons, Ltd. Statist. Med. 2015, 34 2662–2675
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2.5. Incorporation of someone’s historical and prior information into the model
For construction of the likelihood and estimation of the parameters in the model, information about the
person that does not change over time, such as gender and family history, would be included as one of
the fixed covariates Xi.
To capture the differential risk associated with a ‘for reason’ colonoscopy compared with a
colonoscopy scheduled for surveillance, a colonoscopy-varying indicator variable indicating whether the
reason for the colonoscopy was ‘symptoms’ was included in the model. Individuals with a colonoscopy
conducted because of the symptoms are expected to have an increased probability of having an AAC
result. This covariate contributes to the model as a fixed covariate Xij, but varies for each colonoscopy
interval rather than by individual.
The information about a person’s history of COL and FOBTs and their results could be captured by
Zi(a). We will call this their historical record, which includes everything that is known about a person’s
COL/FOBT testing both during and before the study. A sensible model will probably require a vector of
time-dependent covariates, that is, Z1i(a),Z2i(a),… ,Zpi(a) to allow for different aspects of their history
to be important. There is much flexibility in this approach, and there are many different choices that can
be made for the Z’s.
In the analysis of the data, wewere particularly interested in incorporating prior COL and FOBT results
and their impact on risk, and allowing for differences in the impact on risk if the prior COL/FOBT result
was in the recent past compared with in the distant past. The specific choices for Zi(a) we considered
were of the form ‘has the patient had a test with result M in the last P years’. The set of M’s we considered
were hyperplastic/other on a COL, adenoma on a COL, advanced adenoma on a COL, cancer on a COL,
and a positive FOBT. The time frames for P for the COL results we considered were the last 1 year, the
last 1.5 years, the last 5 years and ever during the study period. The time frames considered for P for a
positive FOBT were the last 3 months, the last 6 months, the last 9 months, and the last 1 year. With these
definitions each Z is a time-dependent binary variable. For example, the Z corresponding to having an
advanced adenoma ever during the study period would be coded as zero up to the age of the first finding
of an advanced adenoma on a COL, and then as one at all later ages. The Z corresponding to having a
positive FOBTwithin the last 3months is illustrated in Figure 1 and would be coded as zero up to the time
of the first positive FOBT, would jump to one at that age and remain at one for the next 3months, then
would change to zero at the next age for which there was not a positive FOBT within the last 3months.
It could then subsequently jump up to one again if the patient had a later positive FOBT.
Another intricacy to be considered in this particular situation is the overlapping of the effect of the Z
covariates corresponding to abnormal COL results. Due to the binary nature of the identified Z covari-
ates and the corresponding positive coefficients, an individual with multiple colonoscopies with various
abnormal results in a short period (e.g., adenoma at the first colonoscopy, followed by an advanced ade-
noma within 6months) would have an inflated predicted risk compared with someone with multiple
colonoscopies but with the same, and possibly more severe, abnormal results at all colonoscopies
(e.g., advanced adenoma at the first colonoscopy, followed by an advanced adenoma within 6 months).
In such a situation we would expect that consecutive advanced adenoma results would increase an indi-
vidual’s risk of an AAC finding compared with an adenoma followed by an advanced adenoma. Thus,
the effect of the identified Z matrix covariates was modified to last for the minimum of their chosen P
time frame and the time until the individual’s next colonoscopy result.
The Zi(a)’s described previously capture many aspects of a person’s current and past results of FOBT
and COL tests. The dynamic nature of a person’s sequence of tests is very complex, and it would certainly
be possible to capture more aspects of the timing and results by defining additional Z’s. For example, if
the relevance of a test result differed with age, that could be captured by an interaction of the test result
with a discrete version of age. The set of possible Z’s one could consider is large.
Model selection was conducted based on minimization of model Akaike information criterion
(AIC), which is a goodness-of-fit measure that is defined as AIC= 2×(number of parameters in the
model)−2×(maximized log likelihood). All considered models included the fixed effects of location, gen-
der, risk group, and the colonoscopy-varying covariate of test reason being symptoms. The Z’s considered
to be of interest were those corresponding to having a colonoscopy result of hyperplastic/other, adenoma,
advanced adenoma, and cancer within the past 1, 1.5, and 5 year(s), or ever while under surveillance. A
Z corresponding to ever having any abnormal colonoscopy result, defined here as adenoma, advanced
adenoma, or cancer, during the study period was also included. To account for the effect of FOBTs, we
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considered Z’s corresponding to a positive FOBT within the last 3, 6, and 9months, or 1 year. Including
multiple Z’s corresponding to the same abnormal colonoscopy result (e.g., adenomawithin the past 1 year
and adenoma within the past 1.5 years) in the same model produced a negative coefficient for the corre-
sponding covariate because of multiple covariates trying to describe the same effect. Thus, the selection
of Z’s was conducted by varying the time frame P for a single abnormal result in each model and then
selecting the best combination of time frames for the abnormal COL results based on the model with the
lowest AIC.
2.6. Interpretation of parameters
The 𝛽’s are risk ratios associated with a unit change in the baseline covariates Xi or the reason for test
covariate Xij. The 𝜃’s are the risk ratios associated with unit changes in Z. Thus, for example, if one of the
Z’s was set up to represent any prior abnormal FOBT, then a large positive 𝜃 would suggest that people
who had prior positive FOBTs anytime in the past are at an increased risk of AAC. Similarly, if another
Z was set up to jump from zero to one if a person had an adenoma COL result, then an estimate of 𝜃 near
zero for this Z would suggest that an adenoma result on a COL does not change the assessment of the
subsequent risk of AAC for that person. If we had set up Z to represent at least two prior normal COLs,
this might indicate the person was at lower than normal risk, in which case you would expect the estimate
of 𝜃 to be negative.
The previous discussion illustrates the subtleties in interpretation and possible over-interpretation of
the 𝜃’s. A unique feature of a COL is that it is also an intervention. The procedure attempts to remove any
adenomas that are found, thus decreasing the risk of an adenoma developing into AAC. The described
model specifies the risk of an event as a function of Z(t), where Z(t) represents the results of past testing.
If Z(t) captures colonoscopy testing and results, a person’s actual risk may change as a result of having a
COL. However, even though the COL procedure may reduce that person’s risk because of the removal of
an adenoma, we might still expect to see a positive estimate of 𝜃 because this person is now considered
at higher long-term risk because of what has been learned about them compared with what was known
about them before. In contrast, an FOBT is purely for detection purposes and a positive FOBT indicates
that the person is in a subset of the population with possible increased risk of AAC, but because it is just
a test it does not change that person’s specific probability of advanced adenoma or cancer developing.
Thus, if Z(t) represents FOBTs and their results, the person’s hazard of the event does not change as a
result of the test; yet, we would expect the corresponding 𝜃 to be positive because this person is now
considered at higher risk because of what has been learned about them compared with what was known
about them before. In both of these cases, the result of the test has provided information about the person’s
risk, and this information is being represented by 𝜃 and is useful for making accurate predictions for the
individual. Because our main purpose is prediction, the aforementioned difficulties in interpreting the 𝜃’s
is not an over-riding limitation.
The parameters 𝛼0 and 𝛼1 define how the intensity of experiencing an AAC changes with age. The
specific shape for 𝜆0(a) should not be over-interpreted because it is simply a convenient functional form.
Algebraically, it is the intensity for people who have either had no tests completed or had tests completed
and all the test results are normal or negative. But, because the program enrolled high-risk people who
had previous abnormal findings or were tested during the study, there are very few such people. The
expected increasing nature of 𝜆0(a) is simply a way to capture the idea that if the interval between COLs
is long and the person has an AAC finding at the COL, it is more likely to have occurred towards the
latter part of the interval because the occurrence of cancer and adenomas is more common in older than
in younger people.
2.7. Standard errors
Standard error estimates were obtained using bootstrap methods. Three hundred bootstrap samples were
generated by randomly selecting n (the total number of patients) individuals with replacement from the
original data set. When an individual is selected for a bootstrap sample, all of the individual’s COL and
FOBT data are selected. Bootstrap standard errors account for model overdispersion and for some of the
correlation between the observations on the same individual.
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3. Results
3.1. Parameter estimates
The results are given in Table II. The negative parameter estimate for women indicates that a risk of
AAC is decreased for women compared with men. There is no significant difference in the risk of AAC
between the Melbourne and Adelaide groups, which is a notable finding given that these two studies
had very different recruitment strategies. The coefficient for 𝛼1 is greater than 0, indicating that risk
significantly increases with age. Using the estimate for 𝛼1, we compute that a 70-year old person has
2.5 times the hazard of AAC compared with a 50-year old if all other risk factors were the same. In
comparison with those with a family history of R0, those in the hereditary nonpolyposis colorectal cancer
(HNPCC) definite group have a significant increased risk of AAC. The R3, CCC, and HNPCC-suspected
groups are also of increased risk, but the risk is not significantly different compared with those in R0.
The R1 group has the lowest risk, but it is not statistically significantly different from the R0 group. If the
reason for the COL is because the patient had symptoms, there is a significant increased risk of AAC. All
of the abnormal colonoscopy results provided the best fit when the effect was considered 1 year past the
observed result. A prior colonoscopy result of advanced adenoma produced the greatest increase in risk,
followed by cancer, adenoma, and hyperplastic/other. The Hyperplastic and Other results were grouped
together because they exhibited a similar pattern of AAC event rates when examining the event rate by
previous COL result and time until the next COL. The estimates for all the prior colonoscopy results were
all positive. Thus, the long-term risk associated with an abnormal COL result is greater than the benefit
from having adenomas removed as a result of the COL procedure. A positive FOBT significantly affected
risk when the effect was considered for 3months past the positive result, and the positive coefficient
indicates a significant increased risk for 3months subsequent to a positive FOBT result.
Table II. Parameter estimates.
Model Bootstrap Hazard
Variable Estimate SE SE p-value† Ratio
Age
Intercept (𝛼0) −7.93 0.38 0.44
𝛼1 1.10 0.11 0.13 < 0.001 ***
𝜷
Women −0.13 0.07 0.07 0.08 0.88
Melbourne −0.10 0.11 0.13 0.45 0.90
Symptoms 0.21 0.10 0.10 0.04 * 1.23
Family history‡
R1 −0.26 0.18 0.21 0.23 0.77
R2 −0.10 0.17 0.18 0.55 0.90
R3 0.27 0.15 0.17 0.10 1.31
R4 −0.09 0.12 0.13 0.49 0.91
CCC 0.09 0.27 0.27 0.73 1.10
HNPCC-suspected 0.42 0.19 0.26 0.11 1.52
HNPCC definite 0.53 0.18 0.20 < 0.01 ** 1.70
𝜽
Adenoma< 1 yr 1.59 0.16 0.15 < 0.001 *** 4.90
Advanced adenoma< 1 yr 2.46 0.12 0.13 < 0.001 *** 11.8
Cancer< 1 yr 1.73 0.18 0.18 < 0.001 *** 5.63
Hyperplastic/Other< 1 yr 1.42 0.14 0.15 < 0.001 *** 4.15
Abnormal COL ever during the study period 0.35 0.11 0.11 < 0.01 ** 1.41
Positive FOBT< 3months 1.85 0.19 0.21 < 0.001 *** 6.37
†The p-values are determined using the Bootstrap SEs in a Wald test for significance.
*0.01 < p ⩽ 0.05; **0.001 < p ⩽ 0.01; ***p ⩽ 0.001.
‡Family history covariates are relative to R0. HNPCC, hereditary nonpolyposis colorectal cancer; SE,
standard error.
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Of note from the results is that the risk ratios and significance levels of the updated COL and FOBT
results are much stronger than for the baseline variables. Thus, more recent test results are a much more
important determinant of a person’s risk than family history and gender.
The standard deviations of the bootstrap estimates were similar, although sometimes slightly larger,
than those from the fitted model that uses data from all patients. This suggests that the impact of
overdispersion and within-subject correlation are not large in these data.
3.2. Goodness-of-fit
Calibration plots were used to compare the observed proportion of events with the probability of AAC
predicted by themodel. The estimated values for the probability that the COLwasAAC (i.e., the estimates
of pij from Equation 4) were categorized into bins of observations and the proportion of events observed
within these groups was compared with the median of the bin’s predicted probabilities. Model fit was
evaluated by comparing the agreement between the two. Calibration plots were created for subsets of the
data (e.g., by interval length, patient’s age at observation, and surveillance status) to examine whether
inconsistencies in agreement between predicted and observed proportions are associated with a particular
covariate. Figure 2 shows the overall calibration plot and depicts a generally good agreement between the
predicted probabilities and the observed proportions. The final dot represents fewer COL intervals with a
wider range of prediction probabilities, and thus, the median predicted probability of AAC appears to be
lower than the observed proportion of AAC events for those intervals. In addition, the proposed model
tends to slightly underestimate the risk when the estimated risk of AAC is low. This phenomenon is more
apparent in the examination of calibration plots by interval length, shown in Figure 3. For the intervals
between COLs of less than 1 year, the observed proportion of AAC events is noticeably higher than the
predicted probability of occurrence. The selected model does not fully capture the clinical relevance of
short time between COLs. There are many reasons why a COL may be performed within 1 year of a
previous COL. Some of these are included in the model, but there are others that may not be. For example,
clinical judgment or factors not in the data set may suggest the patient is at higher risk and hence should
return soon for another COL. This would likely lead to a higher probability of a positive COL finding
than what is predicted by the model. Another reason is that the first COL may have been incomplete, or
have given ambiguous or suspicious results, which would then require a ‘follow-up’ colonoscopy. This
would also lead to a higher probability of a positive COL finding than what is predicted by the model.
Although, in constructing the data set considerable effort was given to collapse such ‘follow-up’ COLs
into a single COL, so this may be a minor reason for the higher observed rate.
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Figure 2. Overall calibration plot to compare the model’s predicted probability with the proportion of observed
events. Each dot represents 500 colonoscopy intervals, except for the last bin, which represents 369 intervals. Dots
are centered at the median-predicted probability for the corresponding bin.
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Figure 3. Calibration plot by interval length to compare the model’s predicted probability with the proportion of
observed events. (Left) Each dot represents 200 colonoscopy intervals, except for the last bin, which represents
130 intervals. (Right) Each dot represents 500 colonoscopy intervals, except for the last bin, which represents 51
intervals. Dots are centered at the median-predicted probability for the corresponding bin.
4. Individualized predicted survival distribution of time to a future AAC event
The model can be used to give the individualized survival distribution for time Ti, when the next AAC
event occurs for patient i, given all that is known about that patient up to age A. Specifically, assume the
prediction is to be made for person i at age A. Then, the probability of no new AAC within the next t
years is
S(t) = P{Ti > A + t|age = A,Xi,Zi(A)}
= exp
[
−∫
A+t
A
𝜆i(a)da
] (7)
which is estimated by
exp
[
− exp(𝛽Xi)∫
A+t
A
?̂?0(a) exp{?̂?Zi(a)}da
]
(8)
This calculation requires specification of Zi(a) from the current age A to age A+ t. Thus, we are making
predictions under the assumption that the person will not have any COLs or other tests between age A
and age A + t. Also, note that because the integral is from A to A + t the actual values of Zi(a) for ages
before A do not enter into this calculation; however, someone’s record of COLs and FOBTs prior to age
A may get captured depending on how Zi(a) is defined. Hazard and survival curves can be generated
for individuals following their last follow-up using model estimates. Individuals are considered to be at
increased risk if they have a positive colonoscopy result within the last 1 year or ever during the study
period, depending on the covariate corresponding to that positive result in the model. The reason for the
subsequent colonoscopies is assumed to be not because of symptoms. To represent the risk graphically,
we plot one minus the survival distribution versus time from the current age. The risk (p) of an AAC
can be read from the graph at any desired follow-up time (t). For a person, this risk can be interpreted
in the following way: If there are 1000 people like you, with exactly the same age, family history, and
series of test results, if the next colonoscopy for each of these people is t years in the future, without
any intermediate tests, then 1000 × p of them are expected to have a positive finding of AAC on that
colonoscopy.
As an illustration, Table III describes the colonoscopy and FOBT follow-up data for four hypothetical
patients of varying risk. Patients 1 and 2 are male Melbourne patients with R1 family risk and based on
their test results can be categorized as being low-risk. Patients 3 and 4 are male Melbourne patients with
the more risky HNPCC definite family history. Patient 1 has a different test sequence and all four patients
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Table III. Example of patient historical record for low-risk male Melbourne patients with R1 fam-
ily risk (Patients 1 and 2) and high-risk male Melbourne patients with HNPCC definite family risk
(Patient 3 and Patient 4).
Test result
Age (years) Test Patient 1 Patient 2 Patient 3 Patient 4
52.65 FOBT Negative Negative Negative Negative
53.55 FOBT Negative Negative Negative Negative
54.72 FOBT Positive Positive Positive Positive
55.04 COL Normal Advanced adenoma Adenoma Adenoma
55.29 COL — Adenoma Advanced adenoma Advanced adenoma
55.58 FOBT — Negative Negative Positive
HNPCC, hereditary nonpolyposis colorectal cancer; FOBT, fecal occult blood test; COL, colonoscopy.
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Figure 4. Predicted failure probability (1 − Ŝ(t)) for the next 3 years past the current age of 55.58 years for four
individuals with varying risk, for whom historical records of colonoscopies and fecal occult blood tests are given
in Table III.
have differing test results. In Figure 4, we show the individualized predicted event probability curves for
these four patients, assuming no symptoms and no additional FOBTs for the prediction period. Reading
from the graphs, the 3-year risk for the patients 1, 2, 3, and 4 are 0.02, 0.06, 0.20, and 0.44, respectively.
These graphs were produced using the parameter estimates in Table II and Equation 8. The rate of the
continuous increase of the predicted event probability is determined by the effect of age and the fixed
effects of gender, location, and family risk. Because of the final selected model, a positive FOBT only has
an effect for the subsequent 3months, and a particular abnormal COL only has an effect for the following
1 year. In addition, Patients 2, 3 and 4 have increased risk because of the positive effect of the ‘abnormal
COL ever during the study period’ coefficient. Because of the dynamic nature of the prediction model,
Patients 2 and 3 have different predicted risk trajectories based on the difference in their history of test
results. This would not have been reflected by standard prediction tools that only incorporate the effect
of the most recently observed event.
In the long run, one could imagine a website where a person specifies a horizon of time t and inputs
their values for their current age A, their baseline variables Xi, and their history of COL and FOBT results.
The website will then calculate and output 1 − Ŝ(t), the chance of an AAC within the next t years. This
could be a useful aid in helping to decide when to schedule the next COL or FOBT.
5. Discussion
The proposed model produces prediction of risk in a dynamic manner. As new information becomes
available about a person’s COL and FOBT results, the model incorporates its effects and updates the
predicted risk of developing the outcome of interest. This type of model is particularly useful for the
surveillance data studied in this paper because it incorporates the longitudinal COL and FOBT results
from the frequent testing of this high-risk group. A variety of covariates could have been chosen to capture
the effect of updated test information. Abnormal COL results were found to have a significant effect on
increased AAC risk for 1 year past the abnormal finding. A positive FOBT was found to significantly
increase risk for 3months following the test. The covariates that incorporated the updated information
aspect of the model were of greater significance than the baseline variables.
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The timing of the COLs themselves perhaps carries some information about the disease development.
While many of the reasons a person comes in for a COL are included in the model, such as positive FOBT,
age, symptoms, and regular surveillance, there may be other reasons, such as type of symptoms, other
lab tests, and change in family history, which were not included. These might provide information about
the level of risk, suggesting that if the process of the timing of the COLs had been modeled, additional
information may have been obtained about a person’s risk. Developing such a model would require more
information than what is available in this data set.
The estimation method presented here does not utilize any of the information that may be known about
a person after their last COL. Specifically, we may know the date of death for many people. Quite a
number of people have one or more FOBT after their last COL, and all the FOBT results are negative.
For people such as these, updated predictions like those shown in Figure 4 could be made after the latest
FOBT test, as was illustrated by Patients 2, 3, and 4 in the Figure.
The initial formulation of the model was based on a Poisson process, which lead in a natural way to
a model for the observed binary response data. The binary response model, together with an assumption
of independence gave a likelihood, from which point estimates were obtained. Measures of uncertainty
were obtained using the bootstrap. Thus, the validity of all the aspects of the Poisson process assumptions
is not being relied on. We regard it simply as a good starting point to develop a model.
Some sensitivity analyses were undertaken. The analysis was run separately for the Adelaide and
Melbourne cohorts.We found that the parameter estimateswere quite close to each other, and the location-
specific 95% confidence intervals had considerable overlap for nearly all the parameters. This, together
with the small estimated location effect in Table II, provides justification for combining the data sets in
one model. A second sensitivity analysis was to discretize the intervals into 2months, instead of 1month
intervals. This gave very similar estimates to those shown in Table II and Figure 4.
For the calibration plots in Figures 2 and 3, the predictions are for the same patients which were
used to derive the parameter estimates. As a more honest assessment, leave-one-out cross-validation was
conducted. For each patient, themodel was fit to the data set excluding the patient’s data, and the estimated
coefficients were applied to the left out patient to give predicted probabilities of AAC for that patient’s
intervals. Calibration plots were created using the resulting predicted probabilities and were found to be
very close to those produced by the fitted model. A different form of validation is external validation,
in which predictions are applied to an external data set. We mimicked this by fitting the model to the
Melbourne data and using the estimated coefficients to compute the predicted probabilities of AAC for
the Adelaide data. Calibration plots for the Adelaide data were found to be similar to those in Figures 2
and 3. This provides evidence of generalizability of the fitted model to an independent data set.
There are many ways to consider adapting the presented model or to develop alternative approaches.
For example, including a subject-specific frailty to better accommodate within and between-person het-
erogeneity would be a natural consideration. Such a model formulation would only include frailty terms
in the hazard model and not include the Z’s, but would then require models in which the Z’s are outcome
variables that depend on the frailty. Such a model could be challenging to formulate because it would
require modeling over time the development of all five levels of the COL results and the FOBT results.
In the model we have presented, the Zi terms can be regarded as a substitute for a frailty term, and one
can think of the Zi’s as they are observed and measured as providing information about the frailty. This
is the rationale for not including frailty in the model.
An alternative method for developing dynamic predictions is through landmarking [18]. In this
approach, at each age, a regression model of the residual time to the next AAC event is developed. The
covariates in this model would need to be chosen to represent the current and past history of the per-
son’s tests results and their baseline characteristics. Developing such covariates and implementing this
method using available dynamic model software would be challenging. The regression coefficients for
each covariate themselves depend on age, and these would need to be linked. Overall, this would be a
viable, although complex, approach, and it would be interesting to compare the predictions from such
an approach with the predictions from the stochastic process model developed in this paper. Because the
outcome being modeled is binary, it is also possible to explore a simpler linear logistic model approach.
The challenge with such an approach would be what covariates to use. The length of time since the last
COL could be included to capture the increased risk of AAC for longer intervals between COLs that
results from having more time for advanced adenoma or cancer to develop. However, we think this is less
satisfactory than capturing the effect of the interval width through integrating the intensity function over
the time interval, as in Equations 1 and 4.
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Aspects of the Zi’s can be thought of as ‘internal’ covariates in the Cox model jargon, that is, they
themselves reflect disease progression. There is a reasonably large literature on joint modeling of longi-
tudinally measured covariates together with event times [19, 20]. There are potential biases in estimates
of hazard model parameters if one does not take into account the longitudinal data. This could require
a complex model for the development and progression of adenomas and how they relate to what one
can actually measure. Because the Z’s are internal variables, which can be regarded as outcome vari-
ables, interpretation of the 𝜃’s may be tricky; however, for the purpose of future prediction, this is less of
a concern.
The individualized predictions presented in this paper are intended to be an aid to the patient and physi-
cian to help schedule the next colonoscopy or FOBT. Currently, there are guidelines that a population
can follow. The work presented here would facilitate a more personalized approach. For example, a COL
might be scheduled at the time at which the risk is 10% or at 5 years, whichever is sooner, and a FOBT
might be scheduled at the time at which the risk is 5%.
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